Citations 0
June 17, 1998

Merck-Sponsored Simvastatin (Zocor) Compliance Program for Patients Using Wal-Mart Pharmacy: Of Benefit to Whom?—Reply

Author Affiliations

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor


Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1998

JAMA. 1998;279(23):1875-1876. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-23-jbk0617

In Reply.— Merck strongly supports programs that enhance compliance with medication regimens prescribed by a health care professional and dispensed by a pharmacist. The intended benefits of prescription medications generally can only be achieved when the medication is taken as prescribed.

Dr Hirsch suggests that the true motivation behind Merck's support for the compliance program is primarily financial gain. To support this point, he references another program that encouraged switching of patients from one prescription drug to another. The Merck-sponsored program referred to by Hirsch is not a switch program, but rather a compliance program for those patients for whom Hirsch has prescribed Zocor.

First Page Preview View Large
First page PDF preview
First page PDF preview